Nagot, N., Singata-Madliki, M., Cournil, A., Nalugya, J., Tassembedo, S., Quillet, C., . . . Molès, J. (2021). Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life. Sci Rep.
Citação norma ChicagoNagot, Nicolas, et al. "Growth, Clinical and Neurodevelopmental Outcomes At School Age Are Similar for Children Who Received 1-year Lamivudine or Lopinavir/ritonavir HIV Prophylaxis in Early Life." Sci Rep 2021.
MLA CitationNagot, Nicolas, et al. "Growth, Clinical and Neurodevelopmental Outcomes At School Age Are Similar for Children Who Received 1-year Lamivudine or Lopinavir/ritonavir HIV Prophylaxis in Early Life." Sci Rep 2021.